Loading...
From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Verma, Ajay M. Anusha, Patael Sreedhar, Subramanian Philip, Smith J.
Verma, Ajay M.
Anusha, Patael
Sreedhar, Subramanian
Philip, Smith J.
Abstract
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2021-02
Type
Letter
Collections
Citation
Verma AM, Patel A, Subramanian S, Smith PJ. From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. Lancet Gastroenterol Hepatol. 2021 Feb;6(2):88-89. doi: 10.1016/S2468-1253(20)30392-7.